Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT03652116

Bupivacaine Verus Pethidine for Post Cesarean Section Pain Relief

Subrectal and Subcutaneous Wound Infiltration With Bupivacaine Versus Pethidine for Postcesarean Section Pain Relief: a Randomized Clinical Trial

Sponsor: Ain Shams University

Conditions Obstetric Pain

Interventions Wound infiltration by Bupivacaine Wound infiltration by Pethidine

Updated 4 times since 2018 Last updated: Aug 28, 2018 Started: Apr 21, 2017 Primary completion: Jun 10, 2018 Completion: Aug 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Obstetric Pain and is currently completed. Ain Shams University leads this study, which shows 4 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Sep 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3

First recorded

Apr 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ain Shams University

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt